Literature DB >> 17433018

Case-control study supports extension of surveillance interval after colonoscopic polypectomy to at least 5 yr.

Hermann Brenner1, Jenny Chang-Claude, Christoph M Seiler, Til Stürmer, Michael Hoffmeister.   

Abstract

OBJECTIVE: Colonoscopy with removal of polyps may strongly reduce colorectal cancer (CRC) incidence and mortality. Recommended time intervals to surveillance colonoscopy differ between countries and have recently been extended to 5 yr or longer for the majority of cases in the United States. Whereas previous evidence is mainly based on observations of adenoma recurrence, we aimed to assess risk of CRC occurrence according to time since polypectomy.
METHODS: In a population-based case-control study conducted in Germany, detailed history and results of previous large bowel endoscopies were obtained by interview and from medical records. Risk of CRC among subjects with history of endoscopic polypectomy compared to subjects without previous large bowel endoscopy was assessed according to time since polypectomy among 454 cases with CRC and 391 matched controls.
RESULTS: Odds ratios (95% confidence intervals) of CRC up to 2 yr, 3-5 yr, and 6-10 yr after polypectomy (using subjects without previous endoscopy as reference group) were 0.16 (0.09-0.69), 0.27 (0.08-0.87), and 1.90 (0.67-5.43), respectively. Risk was significantly reduced (odds ratio 0.27, 95% confidence interval 0.10-0.77) within 5 yr even after detection and removal of high-risk polyps (3+ polyps, at least 1 polyp > or =1 cm, at least 1 polyp with villous components). Odds ratios (95% confidence intervals) for the entire 10-yr time interval following polypectomy were 0.50 (0.23-1.12) and 0.36 (0.18-0.76) for patients with recorded high-risk adenomas and other patients, respectively.
CONCLUSIONS: Our study provides empirical support for extension of the surveillance interval after colonoscopic polypectomy to at least 5 yr.

Entities:  

Mesh:

Year:  2007        PMID: 17433018     DOI: 10.1111/j.1572-0241.2007.01231.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  14 in total

1.  Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy.

Authors:  Vaibhav Wadhwa; Yash Jobanputra; Haider Al Taii; Prashanthi N Thota; Rocio Lopez; Suryakanth R Gurudu; Madhusudhan R Sanaka
Journal:  Surg Endosc       Date:  2019-03-29       Impact factor: 4.584

2.  Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; Amanda I Phipps; Michael N Passarelli; William M Grady; Melissa P Upton; Lee-Ching Zhu; John D Potter
Journal:  Am J Gastroenterol       Date:  2012-06-12       Impact factor: 10.864

3.  Five-year risk of colorectal neoplasia after normal baseline colonoscopy in asymptomatic Chinese Mongolian over 50 years of age.

Authors:  Yinglong Huang; Xiaohua Li; Zhaoyang Wang; Bingzhong Su
Journal:  Int J Colorectal Dis       Date:  2012-07-05       Impact factor: 2.571

4.  [Impact of clinical trials for surgery].

Authors:  C M Seiler; M K Diener; C Schuhmacher
Journal:  Chirurg       Date:  2010-04       Impact factor: 0.955

5.  Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site.

Authors:  Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2013-03-03       Impact factor: 4.897

6.  Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas.

Authors:  Andrea N Burnett-Hartman; Polly A Newcomb; John D Potter; Michael N Passarelli; Amanda I Phipps; Michelle A Wurscher; William M Grady; Lee-Ching Zhu; Melissa P Upton; Karen W Makar
Journal:  Cancer Res       Date:  2013-03-28       Impact factor: 12.701

7.  Risk of advanced metachronous colorectal adenoma during long-term follow-up.

Authors:  G Nusko; E G Hahn; U Mansmann
Journal:  Int J Colorectal Dis       Date:  2008-07-03       Impact factor: 2.571

8.  Comparison and combination of blood-based inflammatory markers with faecal occult blood tests for non-invasive colorectal cancer screening.

Authors:  S Tao; U Haug; K Kuhn; H Brenner
Journal:  Br J Cancer       Date:  2012-03-27       Impact factor: 7.640

Review 9.  Importance of postpolypectomy surveillance and postpolypectomy compliance to follow-up screening--review of literature.

Authors:  Sri Rapuri; Jeanne Spencer; Dennis Eckels
Journal:  Int J Colorectal Dis       Date:  2008-01-09       Impact factor: 2.796

10.  Hormone replacement therapy, body mass, and the risk of colorectal cancer among postmenopausal women from Germany.

Authors:  M Hoffmeister; E Raum; J Winter; J Chang-Claude; H Brenner
Journal:  Br J Cancer       Date:  2007-11-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.